The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC
Clinical trial NCT04877821 · COMPLETED
Trial details
- NCT number
- NCT04877821
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2023-08-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.